
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.800 | 3.800 | 0.000 |
Shares | 96.190 | 96.190 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.520 | 17.601 |
Price to Book | 3.041 | 3.969 |
Price to Sales | 1.550 | 4.887 |
Price to Cash Flow | 10.851 | 14.123 |
Dividend Yield | 0.851 | 0.524 |
5 Years Earnings Growth | 4.540 | 8.046 |
Number of long holdings: 61
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 9.22 | 113.59 | +0.80% | |
Vertex | US92532F1003 | 8.93 | 402.90 | -0.10% | |
Amgen | US0311621009 | 8.84 | 294.09 | -1.28% | |
Regeneron Pharma | US75886F1075 | 6.11 | 584.91 | -2.52% | |
AstraZeneca ADR | US0463531089 | 4.71 | 85.49 | +0.21% | |
Alnylam | US02043Q1076 | 4.37 | 451.95 | -0.96% | |
Biogen | US09062X1037 | 2.50 | 154.05 | -3.65% | |
Royalty Pharma | GB00BMVP7Y09 | 2.47 | 36.12 | +0.14% | |
argenx ADR | US04016X1019 | 2.18 | 787.94 | -1.51% | |
Insmed | US4576693075 | 2.11 | 158.28 | +0.71% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1870288849 | 893.62M | 6.06 | 13.31 | - | ||
PG S Listed Private Equity USD P Ac | 458.56M | 3.09 | 21.15 | 12.05 | ||
PG S Listed Infrastructure USD I Ac | 430.64M | 14.47 | 5.62 | 5.41 | ||
LU0803005494 | 2.32M | 5.03 | 7.77 | 2.58 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review